Nutritional was Bioregenx’s largest product and service line in fiscal 2025, bringing in $1.63M of $1.86M (87%).
| Product and Service | FY 2021 | FY 2022 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Nutritional | — | $1.82M | $1.63M | |
| Medical Testing | — | $587.62K | $207.93K | |
| Findit Services | $42.16K | — | — | |
| Wellness Devices | — | — | $25.42K | |
| Other Sales | — | $3.20K | $884 | |
| Sales Of Essential Oils | — | — | — | |
| Total | $42.16K | $2.42M | $1.86M |
Bioregenx brought in $1.86M from its four product and service lines in fiscal 2025, the year ended December 31, 2025. Bioregenx regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $2.42M. Nutritional was the largest at $1.63M (87.4%), ahead of Medical Testing at $207.93K (11.2%) and Wellness Devices at $25.42K (1.4%). The remaining line, Other Sales, brought in $884.
Compared with fiscal 2024, Nutritional fell 10.8% to $1.63M and Medical Testing fell 64.6% to $207.93K.
Bioregenx began breaking out Nutritional in fiscal 2024, Medical Testing in fiscal 2024, Wellness Devices in fiscal 2025 and Other Sales in fiscal 2024. Bioregenx stopped reporting Findit Services as a separate line after fiscal 2022, when it brought in $42.16K.
Customers & Direct Sales was Bioregenx’s largest revenue line in fiscal 2025, bringing in $1.08M of $1.86M (58%).
| Customer | FY 2024 | FY 2025 |
|---|---|---|
| Customers & Direct Sales | $1.37M | $1.08M |
| Medical & Academic | $1.02M | $640.05K |
| Reseller | — | $146.87K |
| Total | $2.39M | $1.86M |
Bioregenx brought in $1.86M from its three revenue lines in fiscal 2025, the year ended December 31, 2025. Bioregenx regrouped these revenue lines after fiscal 2024, so the total does not compare directly with that year's $2.39M. Customers & Direct Sales was the largest at $1.08M (57.8%), ahead of Medical & Academic at $640.05K (34.4%) and Reseller at $146.87K (7.9%).
Compared with fiscal 2024, Customers & Direct Sales fell 21.4% to $1.08M and Medical & Academic fell 37.5% to $640.05K.
Bioregenx began breaking out Reseller in fiscal 2025, when it brought in $146.87K.
Bioregenx (BRGX) reports its revenue by product and service and by customer. In fiscal 2025, Nutritional was its largest product and service line, bringing in $1.63M (87.4% of the total), followed by Medical Testing at $207.93K (11.2%).
Nutritional was Bioregenx's largest product and service line in fiscal 2025, bringing in $1.63M, or 87.4% of the $1.86M total across its four product and service lines.
Customers & Direct Sales was Bioregenx's largest revenue line in fiscal 2025, bringing in $1.08M, or 57.8% of the $1.86M total across its three revenue lines.
Every figure comes from Bioregenx's annual financial filings, as reported. Each line keeps the name Bioregenx gives it, and years follow its fiscal calendar.
Bioregenx's revenue by product and service goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.